Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug more accessible for some patients.

Medicare covers 80% of the cost for a CPAP machine and supplies if you have a specific type of sleep apnea. To get coverage for a CPAP machine, you have to show that you have sleep apnea through a ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...

"It's called GLP-1 receptor," said Dr. Atul Malhotra from the UC San Diego School of Medicine. It’s already FDA-approved to ...

Lilly’s overall growth primarily is driven by sales of Zepbound, approved for obesity and sleep apnea, and Mounjaro, for Type 2 diabetes. Both drugs use the same active ingredient, tirzepatide.

Eligible patients diagnosed by a health-care provider with obesity alone or along with obstructive sleep apnea ... to pay for Zepbound themselves and are enrolled in Medicare or employer ...

This major development ensures that eXciteOSA ® therapy can be more readily accessed by Medicare and Medicaid ... s mission to make root-cause sleep apnea solutions available to patients across ...